Skip to main content
. 2023 Jun 22;9(2):e003143. doi: 10.1136/rmdopen-2023-003143

Table 2.

Clinical and imaging characterisation of patients with PsO prior to PsA onset

Positive association with PsA development No association with PsA development
Pain 4 studies
(PsO=667; incident PsA=99)
0
Joint tenderness 3 studies
(PsO=257; incident PsA=42)
0
Arthralgia 4 studies (1 study only in female)*
(PsO=667; incident PsA=99)
1 study (in male)*
(PsO=410; incident PsA=57)
Subclinical enthesopathy (US in 2 studies, pQCT) 3 studies
(PsO=325; incident PsA=39)
0
Subclinical synovitis (US or MRI) 1 study
(PsO=109; incident PsA=9)
2 studies (PsO=143; incident PsA=18)
Subclinical tenosynovitis (US or MRI) 0 2 studies (PsO=143; incident PsA=18)

*The definition of arthralgia used in these studies were different: in Faustini et al, this was the presence of at least one tender joints; in Zabotti et al, it was recent onset of non-inflammatory joint and/or entheseal pai and in Simon et al in terms of VAS and tender joints.

pQCT, peripheral quantitative tomography; PsA, psoriatic arthritis; PsO, psoriasis; US, ultrasonography.